Bernard Mach
Fondateur chez MaxiVAX SA
Profil
Bernard Mach is the founder of NovImmune SA, founded in 1998, and MaxiVAX SA, founded in 2005 where he holds the title of Director.
He also held the position of Deputy Chairman at Lonza Group AG and was a Director at Serono SA from 1997 to 2007.
Additionally, he was a Professor at the University of Geneva.
Dr. Mach is also the founder of LO FUNDS LIFE SCIENCES EXPERTISE, Biogen MA, Inc. He holds a doctorate degree from The Rockefeller University and the University of Geneva.
Postes actifs de Bernard Mach
| Sociétés | Poste | Début |
|---|---|---|
MaxiVAX SA
 MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Fondateur | 01/01/2005 |
Anciens postes connus de Bernard Mach
| Sociétés | Poste | Fin |
|---|---|---|
| LO FUNDS LIFE SCIENCES EXPERTISE | Fondateur | 28/03/2014 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Directeur/Membre du Conseil | 17/01/2007 |
| University of Geneva | Corporate Officer/Principal | 01/01/1998 |
| NOVIMMUNE SA | Fondateur | - |
| LONZA GROUP AG | Directeur/Membre du Conseil | - |
Formation de Bernard Mach
| The Rockefeller University | Doctorate Degree |
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LONZA GROUP AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
| LO FUNDS LIFE SCIENCES EXPERTISE | Miscellaneous |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Commercial Services |